Clinical Trial Update: Patient-Reported Efficacy of Subcutaneous (SC) Abatacept in Rheumatoid Arthritis (RA) - South Africa

View source ↗

Summary

The study reports patient-reported efficacy of subcutaneous abatacept in rheumatoid arthritis from a completed clinical trial conducted in South Africa.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rheumatoid Arthritis

Drugs mentioned

• Orencia (abatacept) (abatacept)

Snippet

Sponsor: Bristol-Myers Squibb | Conditions: Rheumatoid Arthritis | Status: COMPLETED